These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 38549669)
1. Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma. Feng Y; Wang W; Jiang S; Liu Y; Wang Y; Zhan X; Zhu H; Du G Front Pharmacol; 2024; 15():1343819. PubMed ID: 38549669 [No Abstract] [Full Text] [Related]
2. Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma. Xu K; Li D; Ji K; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Dai H; Sun H Biol Direct; 2024 Aug; 19(1):71. PubMed ID: 39175011 [TBL] [Abstract][Full Text] [Related]
3. Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy. Xu K; Li D; Qian J; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Sun H; Shi G; Dai H; Liu H Front Immunol; 2024; 15():1288240. PubMed ID: 38292868 [TBL] [Abstract][Full Text] [Related]
4. Unveiling the hidden role of disulfidptosis in kidney renal clear cell carcinoma: a prognostic signature for personalized treatment. Ye Y; Zeng S; Hu X Apoptosis; 2024 Jun; 29(5-6):693-708. PubMed ID: 38296888 [TBL] [Abstract][Full Text] [Related]
5. Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma. Feng K; Zhou S; Sheng Y; Lu K; Li C; Liu W; Kong H; Liu H; Mu Y; Zhang L; Zhang Q; Wang J Clin Genitourin Cancer; 2024 Aug; 22(4):102095. PubMed ID: 38833825 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer. Xiong Y; Kong X; Mei H; Wang J; Zhou S Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783 [TBL] [Abstract][Full Text] [Related]
7. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma. Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761 [TBL] [Abstract][Full Text] [Related]
8. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma. Peng K; Wang N; Liu Q; Wang L; Duan X; Xie G; Li J; Ding D J Cancer Res Clin Oncol; 2023 Nov; 149(15):13793-13810. PubMed ID: 37530800 [TBL] [Abstract][Full Text] [Related]
9. Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma. Liu A; Li F; Wang B; Yang L; Xing H; Su C; Gao L; Zhao M; Luo L Front Pharmacol; 2022; 13():1055841. PubMed ID: 36588677 [No Abstract] [Full Text] [Related]
10. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties. Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X Front Immunol; 2023; 14():1191365. PubMed ID: 37426638 [TBL] [Abstract][Full Text] [Related]
11. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma. Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X Front Immunol; 2022; 13():934387. PubMed ID: 35958561 [TBL] [Abstract][Full Text] [Related]
12. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X Front Immunol; 2023; 14():1205250. PubMed ID: 37426643 [TBL] [Abstract][Full Text] [Related]
13. A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing. Liao Z; Cheng Y; Zhang H; Jin X; Sun H; Wang Y; Yan J Front Cell Dev Biol; 2023; 11():1308352. PubMed ID: 38033866 [No Abstract] [Full Text] [Related]
14. Identifying molecular subtypes and tumor microenvironment infiltration signatures in kidney renal clear cell carcinoma based on stemness-associated disulfidptosis genes by integrating machine learning, single-cell analyses and experimental validation. Liu H; Liang X; Tang G; Wang X; Wang Z; Tong L; Mao Q; Ma J; Wu J Heliyon; 2024 Feb; 10(4):e26094. PubMed ID: 38390172 [TBL] [Abstract][Full Text] [Related]
15. A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning. Wang Z; Du X; Lian W; Chen J; Hong C; Li L; Chen D Front Genet; 2023; 14():1193944. PubMed ID: 37456667 [No Abstract] [Full Text] [Related]
16. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma. Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983 [TBL] [Abstract][Full Text] [Related]
17. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer. Pan G; Xie H; Xia Y Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551 [TBL] [Abstract][Full Text] [Related]
18. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role. Zhong S; Chen S; Lin H; Luo Y; He J BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670 [TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of a novel disulfidptosis-related immune checkpoint gene signature in clear cell renal cell carcinoma. Du L; Zhang N; Wang B; Cheng W; Wen J Discov Oncol; 2024 Jun; 15(1):236. PubMed ID: 38904744 [TBL] [Abstract][Full Text] [Related]
20. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma. Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]